The specialized component of pharmaceutical care: access to high-cost medication
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/30447 |
Resumo: | Introduction: Health in Brazil is a right legally guaranteed by the Federal Constitution of 1988, which established the SINGLE HEALTH SYSTEM (SUS). According to Law 8.080/1990, Pharmaceutical Assistance is included in the field of action of the unified health system. Objective: To discuss the Specialized Component of Pharmaceutical Assistance and clarify the pharmacist's attributions, addressing practices and determinations of the Ministry of Health. Methodology: A descriptive systematic review study was carried out, based on articles and publications from the Ministry of Health, following the PRISMA criteria. Articles published between the years 2000 and 2022 and normative acts in force were used. Results and Discussions: References were obtained from 13 normative acts that are still in force and from 13 articles that were published between the years 2000 and 2022. It was observed that non-adherence to the PCDT and the procedures that the Ministry of Health determines in the Normative Act specific, directly influence the therapy of users. It describes the difficulties of users and professionals with the Centralization of Services and health. Conclusion: Access to high-cost medication at CEAF undergoes careful assessments and its availability occurs through the pharmacist present who follows clinical protocols made available by the ministry of health. It is an ethical duty of the pharmacist to provide the necessary guidance to the user, aiming at the guarantee, safety and effectiveness of the therapy, always observing the rational use of the drug. |
id |
UNIFEI_2ccf60a6ec83ca2df60d54a2e8e82911 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/30447 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
The specialized component of pharmaceutical care: access to high-cost medicationEl componente especializado de la atención farmacéutica: acceso a medicamentos de alto costoO componente especializado da assistência farmacêutica: acesso a medicamento de alto custoPharmaceutical careSpecialized componentCEAFHigh cost.Cuidado farmacéuticoComponente especializadoCEAFAlto costo.Assistência farmacêuticaComponente especializadoCEAFAlto custo.Introduction: Health in Brazil is a right legally guaranteed by the Federal Constitution of 1988, which established the SINGLE HEALTH SYSTEM (SUS). According to Law 8.080/1990, Pharmaceutical Assistance is included in the field of action of the unified health system. Objective: To discuss the Specialized Component of Pharmaceutical Assistance and clarify the pharmacist's attributions, addressing practices and determinations of the Ministry of Health. Methodology: A descriptive systematic review study was carried out, based on articles and publications from the Ministry of Health, following the PRISMA criteria. Articles published between the years 2000 and 2022 and normative acts in force were used. Results and Discussions: References were obtained from 13 normative acts that are still in force and from 13 articles that were published between the years 2000 and 2022. It was observed that non-adherence to the PCDT and the procedures that the Ministry of Health determines in the Normative Act specific, directly influence the therapy of users. It describes the difficulties of users and professionals with the Centralization of Services and health. Conclusion: Access to high-cost medication at CEAF undergoes careful assessments and its availability occurs through the pharmacist present who follows clinical protocols made available by the ministry of health. It is an ethical duty of the pharmacist to provide the necessary guidance to the user, aiming at the guarantee, safety and effectiveness of the therapy, always observing the rational use of the drug.Introducción: La salud en Brasil es un derecho legalmente garantizado por la Constitución Federal de 1988, que instituyó el SISTEMA ÚNICO DE SALUD (SUS). De acuerdo con la Ley 8.080/1990, la Asistencia Farmacéutica está incluida en el campo de acción del sistema único de salud. Objetivo: Discutir el Componente Especializado de Asistencia Farmacéutica y aclarar las atribuciones del farmacéutico, abordando prácticas y determinaciones del Ministerio de Salud. Metodología: Se realizó un estudio descriptivo de revisión sistemática, basado en artículos y publicaciones del Ministerio de Salud, siguiendo los criterios PRISMA. Se utilizaron artículos publicados entre los años 2000 y 2022 y actos normativos vigentes. Resultados y Discusiones: Se obtuvieron referencias de 13 actos normativos que aún se encuentran vigentes y de 13 artículos que fueron publicados entre los años 2000 al 2022. Se observó que la no adherencia a la PCDT y a los procedimientos que determina el Ministerio de Salud en el Acto Normativo específico, influye directamente en la terapia de los usuarios. Describe las dificultades de los usuarios y profesionales con la Centralización de Servicios y la salud. Conclusión: El acceso a medicamentos de alto costo en el CEAF pasa por evaluaciones cuidadosas y su disponibilidad ocurre a través del farmacéutico presente que sigue los protocolos clínicos puestos a disposición por el ministerio de salud. Es un deber ético del farmacéutico proporcionar la orientación necesaria al usuario, visando la garantía, seguridad y eficacia de la terapia, observando siempre el uso racional del medicamento.Introdução: A saúde no Brasil é um direito garantido legalmente pela constituição Federal de 1988, a qual foi instituído o SISTEMA ÚNICO DE SAÚDE (SUS). Segundo a Lei 8.080/1990 inclui-se no campo de atuação do sistema único de saúde, a Assistência Farmacêutica. Objetivo: Tratar sobre o Componente Especializado da Assistência Farmacêutica e Esclarecer as atribuições do farmacêutico, abordando práticas e determinações do Ministério da Saúde. Metodologia: Foi realizado um estudo descritivo de revisão sistemática, com base em artigos e publicações do Ministério da Saúde, seguindo os critérios do PRISMA. Foram utilizados artigos publicados entre os anos 2000 há 2022 e atos normativos vigente. Resultados e Discussões: Foram obtidos referencias de 13 atos normativos que ainda estão vigentes e de 13 artigos que foram publicados entre os anos 2000 até 2022. Observou-se que a não adesão aos PCDT e aos procedimentos que o Ministério da Saúde determina em Ato Normativo específico, influenciam diretamente na terapia dos usuários. Descreve as dificuldades dos usuários e dos profissionais com a Centralização dos Serviços e saúde. Conclusão: O acesso ao medicamento de alto custo no CEAF passa por criteriosas avaliações e a sua disponibilidade se dá através do farmacêutico presente que segue Protocolos clínicos disponibilizados pelo ministério da saúde. É um dever ético do farmacêutico fornecer orientações necessárias ao usuário, objetivando a garantia, a segurança e a efetividade da terapêutica, observando sempre o uso racional do medicamento.Research, Society and Development2022-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3044710.33448/rsd-v11i7.30447Research, Society and Development; Vol. 11 No. 7; e47811730447Research, Society and Development; Vol. 11 Núm. 7; e47811730447Research, Society and Development; v. 11 n. 7; e478117304472525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/30447/26072Copyright (c) 2022 Antonio Jose da Silva dos Anjos Junior; Lucas de Souza Pimentel; Nayane Alves de Castro; Anne Cristine Gomes de Almeida https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPimentel, Lucas de Souza Anjos Junior, Antonio Jose da Silva dos Castro, Nayane Alves de Almeida , Anne Cristine Gomes de 2022-06-06T15:12:05Zoai:ojs.pkp.sfu.ca:article/30447Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:47:11.791324Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
The specialized component of pharmaceutical care: access to high-cost medication El componente especializado de la atención farmacéutica: acceso a medicamentos de alto costo O componente especializado da assistência farmacêutica: acesso a medicamento de alto custo |
title |
The specialized component of pharmaceutical care: access to high-cost medication |
spellingShingle |
The specialized component of pharmaceutical care: access to high-cost medication Pimentel, Lucas de Souza Pharmaceutical care Specialized component CEAF High cost. Cuidado farmacéutico Componente especializado CEAF Alto costo. Assistência farmacêutica Componente especializado CEAF Alto custo. |
title_short |
The specialized component of pharmaceutical care: access to high-cost medication |
title_full |
The specialized component of pharmaceutical care: access to high-cost medication |
title_fullStr |
The specialized component of pharmaceutical care: access to high-cost medication |
title_full_unstemmed |
The specialized component of pharmaceutical care: access to high-cost medication |
title_sort |
The specialized component of pharmaceutical care: access to high-cost medication |
author |
Pimentel, Lucas de Souza |
author_facet |
Pimentel, Lucas de Souza Anjos Junior, Antonio Jose da Silva dos Castro, Nayane Alves de Almeida , Anne Cristine Gomes de |
author_role |
author |
author2 |
Anjos Junior, Antonio Jose da Silva dos Castro, Nayane Alves de Almeida , Anne Cristine Gomes de |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Pimentel, Lucas de Souza Anjos Junior, Antonio Jose da Silva dos Castro, Nayane Alves de Almeida , Anne Cristine Gomes de |
dc.subject.por.fl_str_mv |
Pharmaceutical care Specialized component CEAF High cost. Cuidado farmacéutico Componente especializado CEAF Alto costo. Assistência farmacêutica Componente especializado CEAF Alto custo. |
topic |
Pharmaceutical care Specialized component CEAF High cost. Cuidado farmacéutico Componente especializado CEAF Alto costo. Assistência farmacêutica Componente especializado CEAF Alto custo. |
description |
Introduction: Health in Brazil is a right legally guaranteed by the Federal Constitution of 1988, which established the SINGLE HEALTH SYSTEM (SUS). According to Law 8.080/1990, Pharmaceutical Assistance is included in the field of action of the unified health system. Objective: To discuss the Specialized Component of Pharmaceutical Assistance and clarify the pharmacist's attributions, addressing practices and determinations of the Ministry of Health. Methodology: A descriptive systematic review study was carried out, based on articles and publications from the Ministry of Health, following the PRISMA criteria. Articles published between the years 2000 and 2022 and normative acts in force were used. Results and Discussions: References were obtained from 13 normative acts that are still in force and from 13 articles that were published between the years 2000 and 2022. It was observed that non-adherence to the PCDT and the procedures that the Ministry of Health determines in the Normative Act specific, directly influence the therapy of users. It describes the difficulties of users and professionals with the Centralization of Services and health. Conclusion: Access to high-cost medication at CEAF undergoes careful assessments and its availability occurs through the pharmacist present who follows clinical protocols made available by the ministry of health. It is an ethical duty of the pharmacist to provide the necessary guidance to the user, aiming at the guarantee, safety and effectiveness of the therapy, always observing the rational use of the drug. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/30447 10.33448/rsd-v11i7.30447 |
url |
https://rsdjournal.org/index.php/rsd/article/view/30447 |
identifier_str_mv |
10.33448/rsd-v11i7.30447 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/30447/26072 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 7; e47811730447 Research, Society and Development; Vol. 11 Núm. 7; e47811730447 Research, Society and Development; v. 11 n. 7; e47811730447 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052714237034496 |